Relieving Surgical Pain and Nausea with Light Therapy
Launched by NURAN AYŞEN PAMIR AKSOY · Jan 10, 2025
Trial Information
Current as of June 27, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Since the hospital's architecture and clinical operation where the data will be collected have features that prevent patients from different groups from meeting, the single blind feature can be preserved. The pain assessment of the patients will be made with the numerical pain scale, and the nausea assessment will be made with the numerical nausea rating scale. In addition, data will be collected with the Patient Information Form prepared by the researchers in line with the literature.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being a donor for kidney transplantation
- • Not having an obstacle to wearing glasses
- • Being able to communicate verbally
- Exclusion Criteria:
- • Being color blind • Developing post-operative complications during the study period
About Nuran Ayşen Pamir Aksoy
Nuran Ayşen Pamir Aksoy is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a strong background in clinical pharmacology and extensive experience in trial design and implementation, she leads initiatives that prioritize safety, efficacy, and regulatory compliance. Her work focuses on fostering collaboration among multidisciplinary teams, ensuring rigorous adherence to ethical standards, and leveraging innovative methodologies to facilitate groundbreaking studies in various therapeutic areas. Through her leadership, she aims to contribute significantly to the development of new treatments and enhance the overall quality of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Atakent, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported